CD4 and non-small cell lung carcinoma: An investigation of 335 cases of non-small cell lung cancer (NSCLC) showed that an increased number of epithelial CD8+, stromal CD8+ and stromal CD4+ lymphocytes was significantly correlated with improved disease-specific survival.